SARAH BERTZYK: Open Payments
NPI 1316652373 · MENASHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,230 in 83 payments from 9 companies in 2025. Trend: 2023 $1,493 · 2024 $1,745 · 2025 $2,230
Food & beverage: $2,141Education: $89
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $750 |
| ABBVIE INC. | 12 | $363 |
| Madrigal Pharmaceuticals | 9 | $329 |
| Gilead Sciences, Inc. | 9 | $239 |
| Regeneron Healthcare Solutions, Inc. | 13 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $173 |
| GENZYME CORPORATION | 3 | $80 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| PFIZER INC. | 1 | $19 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, ENTYVIO, Livdelzi, IQIRVO, XELJANZ.
Industry payments across WI — which companies pay providers there.
